Your browser is no longer supported. Please, upgrade your browser.
Settings
BHC [NYSE]
Bausch Health Companies Inc.
Index- P/E- EPS (ttm)-3.60 Insider Own2.30% Shs Outstand359.10M Perf Week-4.15%
Market Cap9.82B Forward P/E5.78 EPS next Y4.71 Insider Trans-1.64% Shs Float342.93M Perf Month-3.23%
Income-1287.00M PEG- EPS next Q1.05 Inst Own66.80% Short Float5.29% Perf Quarter-6.96%
Sales8.48B P/S1.16 EPS this Y68.90% Inst Trans19.37% Short Ratio8.29 Perf Half Y-17.36%
Book/sh-1.91 P/B- EPS next Y12.29% ROA-4.20% Target Price36.08 Perf Year56.90%
Cash/sh1.78 P/C15.30 EPS next 5Y3.95% ROE- 52W Range14.86 - 34.80 Perf YTD31.11%
Dividend- P/FCF8.19 EPS past 5Y-13.10% ROI4.10% 52W High-21.64% Beta1.69
Dividend %- Quick Ratio0.80 Sales past 5Y-5.10% Gross Margin71.40% 52W Low83.51% ATR0.70
Employees21600 Current Ratio1.00 Sales Q/Q26.20% Oper. Margin-1.10% RSI (14)39.87 Volatility2.46% 2.40%
OptionableYes Debt/Eq- EPS Q/Q-80.60% Profit Margin-15.20% Rel Volume1.20 Prev Close27.55
ShortableYes LT Debt/Eq- EarningsAug 03 BMO Payout- Avg Volume2.19M Price27.27
Recom2.20 SMA20-4.80% SMA50-3.63% SMA200-3.93% Volume2,628,880 Change-1.02%
Mar-24-21Downgrade BofA Securities Neutral → Underperform $27
Feb-17-21Upgrade RBC Capital Mkts Sector Perform → Outperform $26 → $42
Jan-22-21Downgrade Piper Sandler Overweight → Neutral $25 → $30
Sep-17-20Upgrade BofA Securities Underperform → Neutral $19
Aug-24-20Reiterated H.C. Wainwright Buy $64 → $50
Aug-24-20Reiterated H.C. Wainwright Buy $50 → $64
Jun-17-20Reiterated H.C. Wainwright Buy $50 → $64
Apr-24-20Initiated Citigroup Buy $30
Apr-02-20Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-29-20Downgrade Wolfe Research Outperform → Peer Perform
Jan-22-20Upgrade Wells Fargo Underweight → Equal Weight $32
Dec-12-19Upgrade JP Morgan Neutral → Overweight $32 → $38
Dec-02-19Initiated Goldman Neutral
Oct-25-19Initiated Cowen Outperform $35
Sep-12-19Initiated Guggenheim Buy
Aug-15-19Upgrade TD Securities Hold → Buy
Jul-19-19Initiated Wolfe Research Outperform
Jun-11-19Resumed Barclays Overweight $28
May-13-19Upgrade JP Morgan Underweight → Neutral
Mar-20-19Initiated SunTrust Buy $30
Sep-13-21 08:48AM  
Sep-10-21 02:44PM  
Sep-09-21 06:06PM  
06:01PM  
05:56PM  
Sep-03-21 11:44AM  
Sep-02-21 11:31AM  
07:00AM  
07:00AM  
Sep-01-21 07:00AM  
Aug-31-21 01:25PM  
Aug-19-21 08:23AM  
Aug-17-21 07:39PM  
Aug-15-21 12:00PM  
Aug-13-21 10:05PM  
Aug-11-21 11:33PM  
Aug-09-21 08:14PM  
Aug-07-21 02:00PM  
Aug-05-21 08:24PM  
Aug-04-21 12:00PM  
11:01AM  
06:55AM  
Aug-03-21 10:00PM  
03:53PM  
02:30PM  
11:35AM  
08:40AM  
07:49AM  
07:29AM  
07:09AM  
06:59AM  
06:57AM  
06:45AM  
06:45AM  
Aug-02-21 08:36AM  
07:00AM  
07:00AM  
Jul-29-21 07:00AM  
Jul-28-21 12:10PM  
Jul-27-21 03:02PM  
Jul-22-21 07:00AM  
Jul-19-21 06:59AM  
Jul-12-21 06:59AM  
Jul-07-21 06:59AM  
06:59AM  
Jul-06-21 07:00AM  
07:00AM  
Jul-01-21 07:14AM  
07:00AM  
Jun-23-21 01:25PM  
07:00AM  
07:00AM  
Jun-22-21 07:00AM  
07:00AM  
Jun-21-21 09:56AM  
07:00AM  
07:00AM  
Jun-10-21 01:56AM  
Jun-08-21 11:38AM  
06:59AM  
Jun-07-21 06:46PM  
06:46PM  
Jun-03-21 11:31AM  
05:19AM  
Jun-02-21 06:59AM  
Jun-01-21 06:59AM  
06:59AM  
May-27-21 07:00AM  
07:00AM  
May-25-21 12:07PM  
11:22AM  
07:00AM  
May-24-21 05:30PM  
08:21AM  
08:21AM  
08:20AM  
08:20AM  
May-20-21 05:14PM  
May-17-21 07:00AM  
May-11-21 06:59AM  
May-10-21 04:32PM  
May-06-21 07:00AM  
07:00AM  
May-05-21 11:51AM  
06:55AM  
06:30AM  
May-04-21 11:39AM  
11:26AM  
10:46AM  
08:20AM  
07:52AM  
06:59AM  
06:59AM  
06:15AM  
May-03-21 07:05AM  
07:00AM  
Apr-30-21 12:47PM  
10:29AM  
Apr-29-21 12:36PM  
06:59AM  
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VON ESCHENBACH ANDREW C.DirectorAug 05Buy25.941,40036,31638,647Aug 09 04:13 PM
DE SCHUTTER RICHARD UDirectorAug 04Buy25.0110,000250,123317,109Aug 06 04:24 PM
Eldessouky SamEVP & Chief Financial OfficerJun 11Sale31.6817,000538,586116,857Jun 15 04:11 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELJun 02Option Exercise14.85121,1981,800,029287,956Jun 04 04:51 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELJun 02Sale31.83121,1983,857,732166,758Jun 04 04:51 PM
WECHSLER AMY BDirectorMay 26Sale31.7911,037350,81198,325May 28 04:34 PM
Humphries William D.President, Ortho-DermatologicsDec 04Option Exercise14.38114,0551,640,111349,090Dec 08 04:23 PM
Humphries William D.President, Ortho-DermatologicsDec 04Sale19.87114,0552,266,398235,035Dec 08 04:23 PM
Humphries William D.President, Ortho-DermatologicsNov 27Option Exercise14.3813,663196,474248,698Nov 30 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 27Sale19.6313,663268,207235,035Nov 30 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 24Option Exercise14.3821,658311,442258,176Nov 30 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 24Sale19.6321,658425,196235,035Nov 30 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 23Option Exercise14.381,48321,326236,518Nov 30 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 23Sale19.631,48329,115235,035Nov 30 04:50 PM